Document Detail


Hormone replacement therapy shortens QT dispersion in healthy postmenopausal women.
MedLine Citation:
PMID:  11466136     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The aim of the study was to investigate the effects of hormone replacement therapy (HRT) on myocardial repolarization characteristics in postmenopausal women without coronary artery disease. METHODS: Fifty-one consecutive healthy postmenopausal women (age 48 +/- 5) with negative exercise stress testing were prospectively enrolled into the study. Standard 12-lead electrocardiograms were obtained to evaluate the effects of 6 months of HRT on QT intervals, corrected QT intervals (QTcmax and QTcmin), QT dispersion (QTd), and corrected QTd (QTcd). Hormone regimens were continuous 0.625 mg/day conjugated equine estrogen (CEE) plus 2.5 mg/day medroxyprogesterone acetate (MPA) or 0.625 mg/day CEE alone depending on the hysterectomy status. RESULTS: Although not statistically significant, CEE alone or in combination with MPA increased QTmax and QTmin values. However, the increase in QTmin was greater than the increase in QTmax, which resulted in statistically significant shortening of QTd (P = 0.007 in CEE and P < 0.001 in CEE + MPA groups). There was a significant prolongation of QTcmin values after 6 months in patients assigned to the CEE group (P = 0.001). The QTcd values were significantly shortened by HRT with both regimens (for CEE group 49 +/- 13 ms vs 38 +/- 13 ms, P = 0.01; for CEE + MPA group 49 +/- 14 ms vs 36 +/- 13, P < 0.001). CONCLUSION: HRT significantly decreased the QTd and QTcd in postmenopausal women without coronary artery disease, independent of the addition of MPA to the regimen. This improvement in myocardial repolarization may be one of the mechanisms of the favorable effects of HRT on cardiovascular system. However, the clinical implications of the shortening of QTd in postmenopausal women with HRT must be clarified.
Authors:
A Yildirir; F Aybar; M G Kabakci; H Yarali; E Akgul; O Bukulmez; S L Tokgozoglu; T Gurgan; A Oto
Related Documents :
6940426 - Coronary heart disease in norwegian sea-pilots: part of the occupational hazard?
8335816 - Various intensities of leisure time physical activity in patients with coronary artery ...
1957766 - Exercise as a coronary protective factor.
17558196 - Paraoxonase activity following exercise-based cardiac rehabilitation program.
3604946 - Assessment by a microprocessor of adherence to home-based moderate-intensity exercise t...
3295166 - Alteration of trichostrongylus colubriformis egg permeability by bacillus thuringiensis...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc     Volume:  6     ISSN:  1082-720X     ISO Abbreviation:  Ann Noninvasive Electrocardiol     Publication Date:  2001 Jul 
Date Detail:
Created Date:  2001-07-23     Completed Date:  2001-10-11     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9607443     Medline TA:  Ann Noninvasive Electrocardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  193-7     Citation Subset:  IM    
Affiliation:
Hacettepe University Department of Cardiology, Ankara, Turkey. ayliny@ato.org.tr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Electrocardiography / drug effects*
Estrogen Replacement Therapy*
Estrogens, Conjugated (USP) / therapeutic use
Female
Heart Rate / drug effects
Humans
Medroxyprogesterone Acetate / therapeutic use
Middle Aged
Prospective Studies
Reference Values
Women's Health
Chemical
Reg. No./Substance:
0/Estrogens, Conjugated (USP); 71-58-9/Medroxyprogesterone Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Qt dispersion and mortality in the elderly.
Next Document:  ST variability during the first 4 hours of acute myocardial infarction predicts 1-year mortality.